Roche targets new central nervous system drugs
January 5, 2007Research and Development
Swiss-based Roche has forged a partnership that could lead to the development of new treatments for schizophrenia, cognitive disorders, Parkinson's …
GSK buys Praecis Pharmaceuticals for $59 million
January 4, 2007Research and Development, Sales and Marketing
GlaxoSmithKline has bought US-based biotech company, Praecis, to further boost its novel cancer pipeline.Its acquisition of Praecis Pharmaceuticals follows the …
Diabetic kidney disease drug hits safety obstacle
January 4, 2007Research and Development, Sales and Marketing
Swiss-based biotech company Speedel has axed its current phase III trial of SPP301 in diabetic kidney disease because of patient …
Positive EU opinion for pancreatic cancer drug Tarceva
January 3, 2007Sales and Marketing
Roche and Genentech's Tarceva has received a positive EU opinion for the treatment of metastatic pancreatic cancer and approval is …
Hants NHS hospital becomes first to be run by private sector
January 3, 2007Lymington New Forest Hospital has become the first NHS facility in England to be run entirely by the private sector.Colchester-based …
Are you reaching your customers?
January 3, 2007Sales and Marketing NHS, healthcare, market access, marketing, strategy
The NHS is changing, and it's doing so at a rate faster than at any time in its history. Huge …
Pharma failing to address MRSA drugs market
January 2, 2007Research and Development, Sales and Marketing
News that a new strain of the MRSA bug has reached Europe from the US has left drug developers under …
New consultancy to address pharma’s NHS funding challenge
January 2, 2007Sales and Marketing
A new consultancy has been launched by a team of pharma and NHS veterans to help companies bring new products …
Pfizer launches online pipeline tracker
December 21, 2006Sales and Marketing
Pfizer has launched a new online service which provides detailed insight into its R&D pipeline.The company is taking a lead …
Government accused of ‘fiddling the books’
December 21, 2006A leading GP has accused the government of fiddling the books on the uptake of practice-based commissioning.Dr David Jenner, the …
Novartis enters late-stage trials for new hepatitis C drug
December 21, 2006Research and Development, Sales and Marketing
Novartis, in collaboration with a US biotech company, has initiated phase III trials of a chronic hepatitis C drug that …
The Pharmafocus Interview: Karol Sikora, Doctors for Reform
December 20, 2006Sales and Marketing Doctors for reform, Karol Sikora, NHS
Karol Sikora, is one of the UK’s leading cancer specialists and a high-profile exponent for radical change in the NHS. …
GSK invests millions in new leukaemia drug
December 20, 2006Sales and Marketing
UK-based GlaxoSmithKline has pledged a total of £235 million towards developing and selling a new cancer drug.It has teamed up …
NHS must undergo massive change to meet new waiting list target
December 20, 2006The NHS will have to change radically and rapidly in order to meet a new government target to reduce waiting …
Protherics raises
December 19, 2006Research and Development
UK-based biotech company Protherics has raised £38 million, which will be split in a three-pronged move to expand its development …
GSK’s mock vaccine gets EU positive opinion
December 19, 2006Research and Development
GlaxoSmithKline Biological's mock pandemic flu vaccine has received a positive opinion from EU regulators.Daronix is intended to protect against flu …
Are patients about to take charge?
December 18, 2006Medical Communications, Sales and Marketing NHS, healthcare, information, patients
While debate rages about many aspects of the pharmaceutical industry, one thing is agreed: our world is becoming ever-more patient-centred. …
Confidence in UK medicine safety high
December 15, 2006After heavy criticism of UK medicines regulator the MHRA last year, a new survey found there is widespread confidence in …
Tycerb in landmark cancer trial
December 15, 2006Sales and Marketing
GlaxoSmithKline's Tycerb has entered a landmark global trial in the treatment of aggressive breast cancer.This will be the first phase …
Merck outlines turnaround strategy
December 15, 2006Sales and Marketing
Merck's battle to regain profitability and bring new life to its product pipeline is gathering momentum as its unprecedented reorganisation …
Latest content
FibroFind appoints Lee Borthwick as CEO
